English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [712]
News [2075]
Articles [83]
Editorials [3]
Conferences [53]
elearning [16]
Study reveals imaging approach with potential to detect lung cancer earlier, at the cellular level
Study reveals imaging approach with potential to detect lung cancer earlier, at the cellular level
Lab findings suggest EGFR inhibitors may prevent rhabdomyosarcoma recurrence
Lab findings suggest EGFR inhibitors may prevent rhabdomyosarcoma recurrence
Researchers develop model to predict patients with poor lung cancer outcomes
Researchers develop model to predict patients with poor lung cancer outcomes
Study identifies causes of cancer
Study identifies causes of cancer
Combination immunotherapy improves outcomes for patients with non-small cell lung cancer
Combination immunotherapy improves outcomes for patients with non-small cell lung cancer
A new pathway to shrink cancerous tumours through body’s immune cells
A new pathway to shrink cancerous tumours through body’s immune cells
Particles released by red blood cells are effective carriers for anti-cancer immunotherapy
Particles released by red blood cells are effective carriers for anti-cancer immunotherapy
How air pollution alters lung tissue to increase cancer susceptibility
How air pollution alters lung tissue to increase cancer susceptibility
NICE recommends tepotinib as the first oral MET inhibitor treatment as an option for adult patients with advanced NSCLC with METex14 skipping alterations
NICE recommends tepotinib as the first oral MET inhibitor treatment as an option for adult patients ...
Noncancerous chest CT features for predicting survival in stage I lung cancer
Noncancerous chest CT features for predicting survival in stage I lung cancer
<12345...208>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307